Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Inspira Technologies Signs a Strategic Agreement With Waas Group

Published 10/26/2021, 01:19 PM
Updated 10/26/2021, 01:29 PM

By Sam Boughedda

Investing.com — Medical device maker Inspira Technologies Oxy BHN Ltd (NASDAQ:IINN) announced Tuesday that it has signed an exclusive distribution agreement with Anita Técnica S.L. (WAAS Group).

WAAS Group is a distributor and technical service provider of medical equipment and supplies in Spain.

The news sent Inspira shares flying over 200%, to $7.50 -- an all time high for the stock since its initial public offering in July.

The agreement has an initial seven-year term and will see the companies collaborate on the marketing and deployment of the ART device, a respiratory support system designed to treat deteriorating respiratory failure patients while they are awake and breathing. 

Inspira said the device has the potential to reduce the need for mechanical ventilation across Spain and Portugal.

As part of the deal, WAAS Group is committed to purchasing a minimum of 1040 ART devices and 35,360 disposable units within seven years. 

"Portugal and Spain are important markets in Europe that have extensive experience operating extracorporeal technologies. We see this as an advantage in ensuring the rapid penetration and adoption of our innovative ART device by the local medical community," said Joe Hayon, Inspira Technologies' Co-Founder, President and Chief Financial Officer.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.